PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31773111-2	2019	We present a case of a bisphosphonate-associated peri-implant atypical femur fracture following use of a recon nail for treatment of a prior bisphosphonate-associated atypical femur fracture.	Diphosphonates	23-37	perilipin 1	Homo sapiens	49-53	
31773111-2	2019	We present a case of a bisphosphonate-associated peri-implant atypical femur fracture following use of a recon nail for treatment of a prior bisphosphonate-associated atypical femur fracture.	Diphosphonates	141-155	perilipin 1	Homo sapiens	49-53	
30687667-0	2018	Peri-implant Atypical Fractures Associated with Bisphosphonates: Should this Clinical Entity be Included in the Definition of Atypical Femoral Fracture?	Diphosphonates	48-63	perilipin 1	Homo sapiens	0-4	
30687667-3	2018	Cases of peri-implant fractures associated with bisphosphonate use suggest the emergence of a new clinical entity because they are not currently covered by the definition of atypical femoral fracture.	Diphosphonates	48-62	perilipin 1	Homo sapiens	9-13	
15203955-1	2004	In order to decrease the peri-implant bone loss during the life-time of the implant, oral use of anti-osteoporosis drugs (like bisphosphonates) has been suggested.	Diphosphonates	127-142	perilipin 1	Homo sapiens	25-29